July 30, 2010
By:
William Looney
To shed some light on China's potential, Pharm Exec sat down with Peter Young, President and Managing Partner of Young & Partners, who recently met with government and industry officials to review the investment and M&A climate for medicines.
|
July 8, 2010
By:
William Looney
As Europe sets the pace in slashing drug prices to meet austerity goals industry is seeking fresh ways to control the fallout. Will more dialogue be enough?
|
June 30, 2010
By:
John Smith, Dodge Communications
Survey suggests now is the time for biotechs to bolster communications in a highly charged acquisition atmosphere.
|
December 9, 2009
By:
John Gardner
The rules of the game have changed. While pharmaceutical executives have been busy trying to keep up with a radically shifting marketing landscape, technology has swept in and changed everything marketers held sacred.
|
|
December 8, 2009
By:
Alexandra Kibble
Alexandra Kibble of Thomson Reuters identifies the products and therapy areas to watch next year.
|
November 18, 2009
By:
Emmanuel Le Poul
Allosteric modulators are an emerging class of orally available small molecule drugs that may have multiple advantages compared to traditional drugs.
|
October 28, 2009
By:
Benjamin Curtis
Google opened up a whole new era of social media when it released Sidewiki - a tool that allows anyone to comment on any Web site. Now pharma has a new battle to fight.
|
October 21, 2009
Industry Audit and Company of The year.
|
|
October 19, 2009
Pharm Exec interviews some of this year's emerging leaders to learn their strategies for success.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
